Loading
Total declarations
Companies
▲ Purchases (1 ops.)
▼ Sales (9 ops.)
Latest filing published 14 Apr 2015 for Tempest Therapeutics, Inc., €23k.
Insider track record
Disclosed buys
1
Disclosed sells
9
Signal history
No signal scores available.
Closed purchases
Market purchases
1
Not enough history yet: 1 closed purchase, at least 2 are needed.
Purchases by company
Since each purchase
- -67.5%Entry US$92,430.00 · Close at T+365 US$30,069.00
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
David Harding: trading record in brief
David Harding discloses dealings in 3 companies, chiefly Hologic Inc, Cytyc Corp and Tempest Therapeutics, Inc. In total, 40 filings cover trades dated from 22 October 2007 to 10 April 2014.
The open-market side counts 1 purchase for €23k alongside 9 sales for €4.2M. Taken together, the sales exceed the purchases by €4.2M. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Other entries cover 21 share grants and 8 option exercises. 2015 to date brings 1 purchase and no sales.
The record was last updated on 14 April 2015 with an open-market purchase (€23k) in Tempest Therapeutics, Inc. Filings reach the SEC (Form 4) feed a median of 3 days after the trade. Section 16 rules allow two business days to file each Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to David Harding
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations32 total
1,000 shares@ US$32.23Common StockSEC:0001179110-15-006272:0
Canonical exit: 9 Jul 2014 (T+90)
975 shares@ US$21.11Common StockSEC:0001127602-13-031883:0
10,866 shares@ US$19.30Common StockSEC:0001127602-13-021427:0
11,958 shares0Common StockSEC:0001127602-12-030914:1
441 shares@ US$20.32Common StockSEC:0001127602-12-030433:0
436 shares@ US$20.32Common StockSEC:0001127602-12-030433:1
7,800 shares@ US$18.32Common StockSEC:0001127602-12-026027:0
7,800 shares@ US$20.15Common StockSEC:0001127602-12-026027:1
17,200 shares@ US$20.19Common StockSEC:0001127602-12-025968:0
40,564 shares@ US$18.32Common StockSEC:0001127602-12-025968:1
40,564 shares@ US$20.15Common StockSEC:0001127602-12-025968:2
5,456 shares@ US$18.32Common StockSEC:0001127602-12-025968:3
5,456 shares@ US$20.17Common StockSEC:0001127602-12-025968:4
5,416 shares@ US$18.47Common StockSEC:0001127602-12-001409:0
5,416 shares@ US$18.53Common StockSEC:0001127602-12-001409:1
36,850 shares@ US$18.47Common StockSEC:0001127602-12-001409:2
36,850 shares@ US$18.53Common StockSEC:0001127602-12-001409:3
5,558 shares0Common StockSEC:0001127602-11-029503:0
574 shares@ US$17.09Common StockSEC:0001127602-11-029503:1
539 shares@ US$17.77Common StockSEC:0001127602-11-029503:2
1,357 shares@ US$17.77Common StockSEC:0001127602-11-029503:3
93,308 shares@ US$16.41Common StockSEC:0001417626-11-000034:0
93,308 shares@ US$22.41Common StockSEC:0001417626-11-000034:1
50,000 shares@ US$18.47Common StockSEC:0001417626-11-000034:2
50,000 shares@ US$22.41Common StockSEC:0001417626-11-000034:3
25 of 32 declarations
